Skip to main content

Peer Review reports

From: Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China

Original Submission
25 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
11 Oct 2022 Reviewed Reviewer Report
2 Nov 2022 Reviewed Reviewer Report - Lynn Mcroy
26 Nov 2022 Author responded Author comments - Jin Yang
Resubmission - Version 4
26 Nov 2022 Submitted Manuscript version 4
29 Nov 2022 Author responded Author comments - Jin Yang
Resubmission - Version 5
29 Nov 2022 Submitted Manuscript version 5
4 Dec 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
19 Jan 2023 Editorially accepted
30 Jan 2023 Article published 10.1186/s12885-023-10568-0

You can find further information about peer review here.

Back to article page